BORTOLOT, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 107
EU - Europa 88
NA - Nord America 41
SA - Sud America 13
AF - Africa 4
Totale 253
Nazione #
SG - Singapore 57
US - Stati Uniti d'America 40
CN - Cina 28
IT - Italia 24
DE - Germania 23
RU - Federazione Russa 16
BR - Brasile 12
KR - Corea 11
FR - Francia 6
FI - Finlandia 5
AT - Austria 4
NL - Olanda 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
IL - Israele 2
SA - Arabia Saudita 2
TG - Togo 2
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
EE - Estonia 1
ES - Italia 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 253
Città #
Singapore 39
Hefei 11
Seoul 11
Beijing 8
Düsseldorf 7
Munich 7
Boardman 5
Milan 5
Los Angeles 3
Udine 3
Codroipo 2
Deiva Marina 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Hong Kong 2
Lappeenranta 2
Lauterbourg 2
Lomé 2
Olomouc 2
San Polo di Piave 2
Santa Clara 2
Verona 2
Vienna 2
Xi'an 2
'Asir Region 1
Ankara 1
Ashburn 1
Atibaia 1
Belluno 1
Berlin 1
Bishkek 1
Brooklyn 1
Buenos Aires 1
Campo Grande 1
Casablanca 1
Chandler 1
Changsha 1
Charqueada 1
Contagem 1
Dublin 1
Duque de Caxias 1
Erbil 1
Hamburg 1
Holon 1
Hot Springs 1
Hyderabad 1
Jaguariúna 1
Jaú 1
Lusciano 1
Madalena 1
Manassas 1
Manaus 1
Montreal 1
Nuremberg 1
Ogden 1
Polokwane 1
Ponta Porã 1
Povegliano 1
Richmond 1
Riga 1
Riyadh 1
Tallinn 1
Tel Aviv 1
Treviso 1
Turku 1
Volta Redonda 1
Votuporanga 1
Yuma 1
Zhengzhou 1
Totale 174
Nome #
Assessing the impact of structured reporting on learning how to report lung cancer staging CT: A triple cohort study on inexperienced readers 33
Immunotherapy in NSCLC Patients with Brain Metastases 33
Liquid biopsy in colorectal cancer: Onward and upward 33
Targeted Therapy in Mesotheliomas: Uphill All the Way 30
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials 28
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance 20
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer 19
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications 17
Advancing leptomeningeal metastases treatment in EGFR-mutated non-small cell lung cancer: lessons from the BLOSSOM trial 17
De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence? 17
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches 17
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab 13
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC 12
Totale 289
Categoria #
all - tutte 1.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20239 0 0 3 0 0 3 3 0 0 0 0 0
2023/202424 1 0 0 1 0 0 10 2 1 5 2 2
2024/2025256 15 8 7 11 6 10 16 22 55 25 58 23
Totale 289